Copeptin and the S-100b Protein in Stroke

CompletedOBSERVATIONAL
Enrollment

151

Participants

Timeline

Start Date

May 1, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Vertigo, PeripheralVertigo, Brain StemVertigo; CentralVertigo; Cerebral
Interventions
DIAGNOSTIC_TEST

copeptin, PS100

"Age, sex and time between dizziness onset and ED visit were collected using Resurgences® software. PS100 concentrations were measured on serum samples by electro-chemiluminescence assay. Copeptin concentrations were measured on serum samples by the Kryptor method. The positivity threshold for copeptin was set at strictly above 10 pmol/L and that of PS100 was set at strictly above 0.105 μmol/L.~And after, we compared results with results of brain imaging: Magnetic Resonance Imaging alone, CT scan alone or both. Depending on clinical presentation, the imaging tests were performed during ED stay, during hospitalization or externally. Presence or absence of stroke was established on diffusion-weighted brain MRI . In case of normal contrast CT alone, a specialized opinion should exclude the need for diffusion-weighted MRI according to clinical presentation."

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT03974464 - Copeptin and the S-100b Protein in Stroke | Biotech Hunter | Biotech Hunter